[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 1-6.doi: 10.3736/jcim20100101

• Commentary •     Next Articles

Pay attention to insulin resistance in chronic liver diseases

Guang Ji   

  1. Institute of Digestive Diseases, Department of Gastroenterology of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2009-08-28 Accepted:2009-10-20 Online:2010-01-20 Published:2010-01-15
  • Contact: Guang Ji E-mail:jiliver@vip.sina.com

Insulin resistance exists in various chronic liver diseases such as fatty liver disease, liver cirrhosis, hepatitis, etc. Insulin resistance not only participates in the development of chronic liver diseases but also affects the efficacy of drug treatment. Paying more attention to diagnosis and treatment of insulin resistance will enhance the therapeutic effect and improve the prognosis of the patients. Traditional Chinese medicine has displayed its characteristics and advantage in treating insulin resistance. Investigation to chronic liver diseases based on lifestyle interference, exploration of the syndrome mechanism of insulin resistance, and scientific evaluation of the efficacy of Chinese herbal prescriptions will contribute to the research of traditional Chinese medicine in preventing and treating insulin resistance in chronic liver diseases.

Key words: Chronic liver disease, Insulin resistance, Traditional Chinese medicine

[1] Paul A . Nonalcoholic fatty liver disease[J]. N Engl J Med, 2002,346(16):1221-1231
doi: 10.1056/NEJMra011775
[2] Brunt EM . Nonalcoholic steatohepatitis[J]. Semin Liver Dis, 2004,24(1):3-20
[3] Bloomgarden ZT . American Association of Clinical Endocrinologists(AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC[J]. Diabetes Care, 2003,26(3):933-939
doi: 10.2337/diacare.26.3.933
[4] Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L . Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance[J]. Gut, 2004,53(7):1020-1023
doi: 10.1136/gut.2003.027086
[5] Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, Scapa EF, Agarwal C, Carey MC, Stephanopoulos G, Cohen DE, King GL, Ginsberg HN, Kahn CR . Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis[J]. Cell Metab, 2008,7(2):125-134
doi: 10.1016/j.cmet.2007.11.013
[6] Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS . Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults[J]. Arch Intern Med, 2004,164(19):2169-2175
doi: 10.1001/archinte.164.19.2169 pmid: 15505132
[7] Wada J . Vaspin: a novel serpin with insulin-sensitizing effects[J]. Expert Opin Investig Drugs, 2008,17(3):3272-3273
doi: 10.1517/13543784.17.3.327 pmid: 18321232
[8] Ye J . Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle[J]. Endocr Metab Immune Disord Drug Targets, 2007,7(1):65-74
doi: 10.2174/187153007780059423
[9] Allison ME, Wreghitt T, Palmer CR, Alexander GJ . Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population[J]. J Hepatol, 1994,21(6):1135-1139
doi: 10.1016/S0168-8278(05)80631-2
[10] Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J , O’Rahilly S, Shore S, Tom BD, Alexander GJ.Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection[J]. Hepatology, 1999,30(4):1059-1063
doi: 10.1002/(ISSN)1527-3350
[11] Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP . Association of diabetes mellitus and chronic hepatitis C virus infection[J]. Hepatology, 1999,29(2):328-333
doi: 10.1002/hep.510290235 pmid: 9918906
[12] Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A . Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection[J]. Mayo Clin Proc, 2000,75(4):355-359
doi: 10.4065/75.4.355
[13] Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M.Thomas DL . Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States[J]. Ann Intern Med, 2000,133(8):592-599
doi: 10.7326/0003-4819-133-8-200010170-00009
[14] Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL . Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B[J]. Gut, 2009,58(1):111-117
doi: 10.1136/gut.2008.157735 pmid: 18832522
[15] Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P . Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C[J]. Gastroenterology, 2008,135(3):821-829
doi: 10.1053/j.gastro.2008.05.044 pmid: 18593587
[16] Tabaru A, Narita R, Hiura M, Abe S, Otsuki M . Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a[J]. Am J Gastroenterol, 2005,100(4):862-867
doi: 10.1111/ajg.2005.100.issue-4
[17] Park SH, Kim DJ, Lee HY . Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection[J]. Am J Gastroenterol, 2009,104(5):1135-1139
doi: 10.1038/ajg.2009.6
[18] Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS . Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis[J]. J Gastroenterol Hepatol, 2008,23(5):679-681
doi: 10.1111/j.1440-1746.2008.05361.x pmid: 18410599
[19] Machado MV, Cortez-Pinto H . Insulin resistance and steatosis in chronic hepatitis C[J]. Ann Hepatol, 2009,8(Suppl 1):S67-S75
doi: 10.1152/ajpgi.90298.2008 pmid: 19381127
[20] Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P . Hepatitis C virus-associated hypobeta-lipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis[J]. Am J Gastroenterol, 2003,98(5):1150-1154
[21] Demelia L, Civolani A, Murgia D, Murru A, Sorbello O, Rizzetto M . Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency[J]. J Hepatol, 2007,46(1):171-173
doi: 10.1016/j.jhep.2006.10.003
[22] Grasso A, Malfatti F, Leo PD, Martines H, Fabris P, Toscanini F, Anselmo M, Menardo G . Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin[J]. J Hepatol, 2009,51(6):984-990
doi: 10.1016/j.jhep.2009.07.008
[23] Thomopoulos KC, Theocharis GJ, Tsamantas AC, Siagris D, Dimitropoulou D, Gogos CA, Labropoulou-Karatza C . Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C[J]. Euro J Gastroenterol Hepatol, 2005,17(2):149-153
doi: 10.1097/00042737-200502000-00004
[24] Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K . Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection[J]. Cancer, 2003,97(12):2948-2950
doi: 10.1002/(ISSN)1097-0142
[25] Castéra L, Hézode C, Roudot-Thoraval F, Lonjon I, Zafrani ES, Pawlotsky JM, Dhumeaux D . Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis[J]. Gut, 2004,53(3):420-424
doi: 10.1136/gut.2002.009936
[26] Fan JG . Research on fatty liver disease in 2008[J]. Zhonghua Gan Zang Bing Za Zhi, 2009,17(2):85-87
doi: 10.3760/cma.j.issn.1007-3418.2009.02.002
范建高 . 2008年脂肪性肝病研究进展[J]. 中华肝脏病杂志, 2009,17(2):85-87
doi: 10.3760/cma.j.issn.1007-3418.2009.02.002
[27] Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G . Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine[J]. J Clin Endocrinol Metab, 2008,93(7):2559-2565
doi: 10.1210/jc.2007-2404
[28] Xiao FY, Hu AM, Zheng Y, Wang JH . Effects of Tangganjian on glucose-lipid metabolism and transaminase in rats with diabetes mellitus and fatty liver disease[J]. Zhongguo Lao Nian Yi Xue Za Zhi, 2007,27(16):1560-1562
肖凤英, 胡爱明, 郑云, 王建华 . 糖肝煎对糖尿病性脂肪肝模型大鼠糖脂代谢及氨的影响[J]. 中国老年医学杂志, 2007,27(16):1560-1562
[29] He CY, Fu XD, Li B, He YM, Chen WH, Ying J, Wang WJ . Effects of “Yiqi Sanju Formula” on levels of some adipocytokines in central obese men[J]. Shanghai Zhong Yi Yao Za Zhi, 2007,41(8):16-18
何春燕, 傅晓东, 李玢, 何燕铭, 陈伟华, 应健, 王文健 . 益气散聚方对中心性肥胖男性相关脂肪细胞因子水平的影响[J]. 上海中医药杂志, 2007,41(8):16-18
[30] Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA . Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project[J]. JAMA, 2004,292(12):1433-1439
doi: 10.1001/jama.292.12.1433
[1] Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance. Journal of Chinese Integrative Medicine, 2012, 10(8): 886-893.
[2] Dong-mei Zhang, Li-xia Lou, Ai-ming Wu, Xi-ying Lü, Zhao-juan Hu, Yan-hong Zhang, Hong-fang Liu. Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(7): 821-826.
[3] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[4] Hong-bo Cao, Hong-cai Shang . Connotations and extensions of comparative effectiveness research and feasibility analysis for clinical evaluation in traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(4): 369-374.
[5] Wang Yun-fei, Que Hua-fa, Xu Jie-nan, Tang Han-jun, Xiang Huan-yu, Liu Xiao-dong, Zhang Zhen, Xing Jie, Shen Liang, Shan Wei, Liu An-min, Qiu Lian-yin, Deng Da-yi, Gao Dan. Assessment of external methods of traditional Chinese medicine in patients with chronic ulcer of the lower extremities: study protocol of a multicenter, randomized, parallel-group, prospective trial. Journal of Chinese Integrative Medicine, 2012, 10(2): 166-175.
[6] You-hua Wang , Shang Li , Bin-rui Yang , Lun-qing Zhang , Xin Zhou , Bei-wen Xu, Ming-yuan Li . Use of zebrafish models for the research of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1189-1197.
[7] Liu Yue, Xie Ming, Zhang Ye. Dynamic changes of laboratory parameters of rats with type 2 diabetes and insulin resistance: defining their role in development of traditional Chinese medicine syndrome. Journal of Chinese Integrative Medicine, 2012, 10(1): 100-108.
[8] Susuana Kuek, Wen-jun Wang, Sui-qi Gui. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(9): 965-972.
[9] Xing-jiang Xiong, Jie Wang. Experience of diagnosis and treatment of exogenous high-grade fever. Journal of Chinese Integrative Medicine, 2011, 9(6): 681-687.
[10] Ming Ren, Wei-wei Liu, Zeng-tao Sun, Ji-hong Feng, Hong-cai Shang. Concept and significance of a subjective and multiple index system of clinical evaluation for traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2011, 9(6): 588-591.
[11] Ya Yuwen, Xue-jie Han, Li-ying Wang, Nan-nan Shi, Yong-yan Wang, Ai-ping Lü. Thinking on methods for formulating development strategy of traditional Chinese medicine standardization. Journal of Chinese Integrative Medicine, 2011, 9(5): 483-486.
[12] Hong-ming Nie, Yue-qiu Gao, Jian-jie Chen. Syndrome distribution among patients with chronic hepatitis C and interventions of integrated traditional Chinese and Western medicine: Study protocol. Journal of Chinese Integrative Medicine, 2011, 9(4): 365-373.
[13] Ju-yong Wang, Ling Xu, Rui-xin Zhang, Lixing Lao. Traditional Chinese medicine for cancer pain. Journal of Chinese Integrative Medicine, 2011, 9(2): 129-134.
[14] Li Dong-tao, Li Fu-yu, Wang Jian, Liu Ji-hong, Yan Nan, Cheng Yong-mei, Hu Ai-hua, Jiang Hong-yang, Shi Feng-lei, Zhang Mei-zeng, Li Jie, Wei Ling-bo, Jiang Rong-qin. A study of diagnostic criteria for traditional Chinese medicine syndromes in osteoporosis. Journal of Chinese Integrative Medicine, 2011, 9(12): 1326-1332.
[15] Fa-wei Wang, Li-ping Chen, Jian Hu, Gang Zhang. Use of traditional Chinese medicine during the Red Army period in Chinese history. Journal of Chinese Integrative Medicine, 2011, 9(10): 1145-1149.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[an error occurred while processing this directive]